Guidance for Industry - Content and Format of Chemistry, Manufacturing and...
...This section should contain information on the stability of the drug substance and any in-process material.....If the drug product is frozen, data supporting the stability of the product through a stated number of freeze-thaw cycles should be.....Verification of the stability of the drug substance under the conditions described should..
http://www.fda.gov/cber/gdlns/cmcvacc.htm (score=100)

Bioanalytical Method Validation
...The stability of the drug and the internal standard should be assessed over the anticipated run time for.....The stability of stock solutions of drug and the internal standard should be evaluated at room temperature for at least 6.....Stability procedures should evaluate the stability of the analytes during sample..
http://www.fda.gov/cder/guidance/4252fnl.htm (score=100)

þÿ
...solutions of the analyte for stability evaluation should be prepared in an appropriate.....This guidance represents the Food and Drug Administration's current thinking on this topic.....For compounds with potentially labile metabolites, the stability of analyte in matrix from..
http://www.fda.gov/cder/guidance/4252fnl.pdf (score=100)

J:!GUIDANCFINALICHQ1C.PDF
...Stability protocols for new dosage forms should follow the guidance in the parent.....the Drug Information Branch, HFD-210, Center for Drug Evaluation and Research (CDER), 5600.....submitted regarding stability of new dosage forms by the owner of the original application..
http://www.fda.gov/cder/guidance/1319fnl.pdf (score=39)

MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....The guidance sets forth information that should be provided to ensure continuing drug..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=37)

HUMAN DRUG CGMP NOTES June 1966
...used in the delivery of a medical drug product is considered an integral part of the drug.....Where stability testing reveals that the BPC is stable for the intended period of use, or.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human..
http://www.fda.gov/cder/hdn/hdn696.htm (score=36)

Human Drug Notes
...Where an expiration dating period is derived from stability studies conducted on the.....Welcome to the first edition of our fourth year of Human Drug CGMP Notes, our periodic.....A potential problem to avoid with using recycled solvents is the possible retention of..
http://www.fda.gov/cder/hdn/hdn396.htm (score=36)

Human Drug Notes
...In the latter case, until appropriate stability data is generated, the expiration date.....Should sterile drug process inspections continue to focus on sterile filtration validation.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human..
http://www.fda.gov/cder/hdn/hdn1295.htm (score=36)

Format and Content for the CMC Section of an Annual Report
...the design of stability protocols, the amount of stability data that should be provided to.....Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....changed container and closure system in stability studies using the..approved stability..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=36)

Human Drug Notes
...While the expiration dating assigned to such products would be based on the stability of the drug product, stability.....The retention time is at least one year after the expiration date of the drug product, or, in the case of some OTC drug products.....Stability/Expiration Dates Barry Rothman 594-0098 Sterile Facility Construction (Clean..
http://www.fda.gov/cder/hdn/hdn995.htm (score=35)

HUMAN DRUG CGMP NOTES September 1996
...Failing to submit annual reports or excluding specific lots from the stability program in.....What types of failures must a batch of new drug product exhibit to trigger a field alert.....Inaccurate/untrue information relative to the production of the bio-batch or stability..
http://www.fda.gov/cder/hdn/hdn996.htm (score=35)

HUMAN DRUG CGMP NOTES September 1998
...Similarly, if stability testing that is supposed to be performed prior to the end of the.....Welcome to another issue of Human Drug CGMP Notes, our periodic memo on CGMP for human use.....Such an investigation may entail testing other lots to ensure the product's stability..
http://www.fda.gov/cder/hdn/cnotes98.htm (score=35)

Microsoft Word - 5666fnl.doc
...8 In June 1998, the Agency issued a draft guidance on stability testing, Stability Testing of Drug Substances.....lot-to-lot variability, the stability and quality of drug products with extended.....for that product based on acceptable data from full, long-term stability studies on at..
http://www.fda.gov/cder/guidance/5666fnl.pdf (score=35)

HUMAN DRUG CGMP NOTES June 1998
...If the kits contain drugs that are subject to the new drug provisions in the Food Drug and Cosmetic Act, the sterile.....166, Stability testing, and 211.167, Special testing requirements; Compliance Policy Guide.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human..
http://www.fda.gov/cder/hdn/cnotes68.htm (score=35)

HUMAN DRUG CGMP NOTES December, 1996
...Is it acceptable for a firm to use drug components, drug product containers, or drug product closures simultaneously with testing and.....However, because the technology may not have been available, older applications lacking.....Is it acceptable for a firm to use drug components, drug product containers, or drug product closures simultaneously with testing and..
http://www.fda.gov/cder/hdn/cnotesd6.htm (score=35)

HUMAN DRUG CGMP NOTES March 1998
...For example, microbial content that adversely affects product stability, would be.....Is the employment of HIV infected workers in drug manufacturing facilities in conformance.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human..
http://www.fda.gov/cder/hdn/cnotes38.htm (score=35)

HUMAN DRUG CGMP NOTES March 1999
...Should investigators cite firms for not conducting accelerated stability testing during.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....Should investigators cite firms for not conducting accelerated stability testing during..
http://www.fda.gov/cder/hdn/cnotes39.htm (score=35)

Forest Laboratories, Inc. Warning Letter
...Results of stability testing are not used in determining appropriate storage conditions.....The notice stated that levothyroxine sodium drug products are used to treat hypothyroidism.....Stability testing showed at least one unit dose packaging system was failing potency..
http://www.fda.gov/foi/warning_letters/g4190d.htm (score=34)

...Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....Observations About KI Tablet Stability Based on Historical Data Potassium Iodide Tablets.....Department of Health and Human Services Food and Drug Administration Center for Drug..
http://www.fda.gov/cder/guidance/5666fnl.doc (score=34)

HUMAN DRUG CGMP NOTES September 1997
...Accelerated stability testing was not practical because the drugs containing iron, mostly.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....This is a temporary guidance which includes provisions for conducting concurrent stability..
http://www.fda.gov/cder/hdn/cnotes97.htm (score=34)

Las Vegas Injury Lawyer